AAVANTI Trademark

Trademark Overview

On Wednesday, March 27, 2019, a trademark application was filed for AAVANTI with the United States Patent and Trademark Office. The USPTO has given the AAVANTI trademark a serial number of 88359936. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, January 1, 2020. This trademark is owned by Aavanti LLC. The AAVANTI trademark is filed in the Pharmaceutical Products category with the following description:

Biological treatment for use for clinical, medicinal and the therapeutic treatment of Friedreich's Ataxia and genetic disorders; biological preparations for the treatment of Friedreich's Ataxia and genetic disorders; biological preparations and biospecific reagents for use in immunotherapy for the treatment of Friedreich's Ataxia and genetic disorders; biological drugs for use for clinical, medicinal and therapeutic treatment of Friedreich's Ataxia; biological drugs for treatment of genetic diseases and Friedreich's Ataxia; biological drugs for use in treating Friedreich's Ataxia and autoimmunity disorders and diseases; gene therapy products, namely, therapeutics for the treatment of Friedreich's Ataxia, autoimmune, immune system diseases and disorders; pharmaceutical preparations for human use for the treatment of Friedreich's Ataxia; therapeutic and medical diagnostic agents and preparations for use in therapies for Friedreich's Ataxia and autoimmunity; therapeutic and diagnostic age...
aavanti

General Information

Serial Number88359936
Word MarkAAVANTI
Filing DateWednesday, March 27, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, January 1, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesBiological treatment for use for clinical, medicinal and the therapeutic treatment of Friedreich's Ataxia and genetic disorders; biological preparations for the treatment of Friedreich's Ataxia and genetic disorders; biological preparations and biospecific reagents for use in immunotherapy for the treatment of Friedreich's Ataxia and genetic disorders; biological drugs for use for clinical, medicinal and therapeutic treatment of Friedreich's Ataxia; biological drugs for treatment of genetic diseases and Friedreich's Ataxia; biological drugs for use in treating Friedreich's Ataxia and autoimmunity disorders and diseases; gene therapy products, namely, therapeutics for the treatment of Friedreich's Ataxia, autoimmune, immune system diseases and disorders; pharmaceutical preparations for human use for the treatment of Friedreich's Ataxia; therapeutic and medical diagnostic agents and preparations for use in therapies for Friedreich's Ataxia and autoimmunity; therapeutic and diagnostic agents, preparations and substances for medical purposes for targeting application to immunotherapies and therapeutic and diagnostic agents

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 15, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAAVANTIBIO, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressGAINESVILLE, FL 32601
Party NameAavanti LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressGainesville, FL 32601

Trademark Events

Event DateEvent Description
Thursday, January 2, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, January 1, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, October 2, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, June 12, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 12, 2019NON-FINAL ACTION E-MAILED
Wednesday, June 12, 2019NON-FINAL ACTION WRITTEN
Thursday, June 6, 2019ASSIGNED TO EXAMINER
Monday, April 15, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 30, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

aavanti friedreich ataxia treatment biological disorders therapeutic genetic preparations drugs diseases